Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
4.830
+0.130 (2.77%)
May 20, 2026, 4:00 PM EDT - Market closed
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $111.05 million as of May 21, 2026. Its market cap has increased by 23.96% in one year.
Market Cap
111.05M
Enterprise Value
6.18M
1-Year Change
23.96%
Ranking
Category
Stock Price
$4.83
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $111.05M, a decrease of -48.23%. That is a compound annual growth rate of -43.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 111.05M | -29.65% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cognition Therapeutics | 115.27M |
| Alps Group | 114.12M |
| Rani Therapeutics Holdings | 108.80M |
| Coya Therapeutics | 108.37M |
| Cibus | 108.32M |
| enGene Therapeutics | 107.85M |
| Verrica Pharmaceuticals | 103.42M |
| Vivani Medical | 102.62M |